Since the advent of combination antiretroviral therapy (ART), a shift in mortality and morbidity has been noted in people living with HIV from AIDS to non-AIDS diseases, among which non-AIDS-defining cancers are prominent.1 In people living with HIV, lung cancer is more common than any other non-AIDS-defining malignant disease, and mortality associated with lung cancer exceeds that associated with any other AIDS-defining or non-AIDS-defining cancers.